Skip to content
Ina HF Carmet
Indonesian Heart Failure and Cardiometabolic Disease Working Group
Ina HF CarmetIna HF Carmet
  • Home
  • About
    • About InaHF
    • Committee
    • Members
  • News
  • Events
    • Event
    • Past Event
  • Recording
  • HF Clinic
  • LIB & Guidelines
    • InaHF Position Statements
    • InaHF National Guidelines
    • International Guidelines
    • Member Publication
  • i-HEFCARD
    • i-HEFCARD 2024
      • i-HEFCARD 2024 Day 1
      • i-HEFCARD 2024 Day 2
    • i-HEFCARD 2023
      • i-HEFCARD 2023 Day 1
      • i-HEFCARD 2023 Day 2
i-TREAT HFHF Unfolded Podcast
Close
  • Home
  • About
    • About InaHF
    • Committee
    • Members
  • News
  • Events
    • Event
    • Past Event
  • Recording
  • HF Clinic
  • LIB & Guidelines
    • InaHF Position Statements
    • InaHF National Guidelines
    • International Guidelines
    • Member Publication
  • i-HEFCARD
    • i-HEFCARD 2024
      • i-HEFCARD 2024 Day 1
      • i-HEFCARD 2024 Day 2
    • i-HEFCARD 2023
      • i-HEFCARD 2023 Day 1
      • i-HEFCARD 2023 Day 2

How can we shift from conventional to collaborative therapy with all HF drugs?

You are here:
  1. Home
  2. Library
  3. How can we shift from…
View Fullscreen

How can we shift from conventional to collaborative therapy with all HF drugs?
dr. Hawani Sasmaya SpJP(K)

Download PDF

National Cardiovascular Center Harapan Kita
Division of Clinical Cardiology, Ward No 2, Level 4
Letjen S. Parman Street No.Kav.87,
RT.1/RW.8, North Bambu City
Palmerah, West Jakarta City, Jakarta 11420.
Follow Us

Find us on:

Twitter page opens in new windowYouTube page opens in new windowInstagram page opens in new windowMail page opens in new window

© 2025 INA HF CARMET. All Rights Reserved

Developed & Managed by ahaa media

Go to Top